These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7643918)

  • 21. Involvement of the kallikrein-kinin system in the salivary secretion elicited in rats by heat stress.
    Damas J
    Braz J Med Biol Res; 1994 Aug; 27(8):2013-20. PubMed ID: 7538374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic inhibition of bradykinin B2-receptors enhances the slow vasopressor response to angiotensin II.
    Madeddu P; Parpaglia PP; Demontis MP; Varoni MV; Fattaccio MC; Glorioso N
    Hypertension; 1994 May; 23(5):646-52. PubMed ID: 8175175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological characterization of a new highly potent B2 receptor antagonist (HOE 140: D-Arg-[Hyp3,Thi5,D-Tic7,Qic8]bradykinin).
    Rhaleb NE; Rouissi N; Jukic D; Regoli D; Henke S; Breipohl G; Knolle J
    Eur J Pharmacol; 1992 Jan; 210(2):115-20. PubMed ID: 1601053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro effects of HOE 140 in human bronchial and vascular tissue.
    Félétou M; Martin CA; Molimard M; Naline E; Germain M; Thurieau C; Fauchère JL; Canet E; Advenier C
    Eur J Pharmacol; 1995 Feb; 274(1-3):57-64. PubMed ID: 7768281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the mechanisms underlying the biphasic responses to bradykinin in circular muscle from guinea pig ileum.
    Medeiros YS; Calixto JB
    Eur J Pharmacol; 1993 Sep; 241(2-3):157-63. PubMed ID: 8243551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Participation of the kallikrein-kinin-receptor system in reflexes arising from neural afferents in the dog epicardium.
    Staszewska-Woolley J; Woolley G
    J Physiol; 1989 Dec; 419():33-44. PubMed ID: 2576069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxytocin-induced natriuresis mediated by the renal kallikrein-kinin system in anesthetized male rats.
    Adachi K; Majima M; Katori M; Nishijima M
    Jpn J Pharmacol; 1995 Mar; 67(3):243-52. PubMed ID: 7630042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the mechanism of rat uterus desensitization to kallikrein.
    Heneine IF; Feitosa MH; Beraldo WT; Oliveira GM; Pesquero JL
    Agents Actions Suppl; 1992; 38 ( Pt 2)():115-9. PubMed ID: 1462820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the bradykinin receptor in the human nasal airway using the binding of [125I]-Hoe 140.
    Dear JW; Wirth K; Scadding GK; Foreman JC
    Br J Pharmacol; 1996 Nov; 119(5):1054-62. PubMed ID: 8922758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Further characterization of monoclonal antibodies against rat plasma kallikrein, rat low molecular weight kininogen and synthetic bradykinin.
    Bedi GS; Back N
    Adv Exp Med Biol; 1989; 247B():223-30. PubMed ID: 2610064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular effects of brain kinin receptor blockade in spontaneously hypertensive rats.
    Madeddu P; Glorioso N; Varoni MV; Demontis MP; Fattaccio MC; Anania V
    Hypertension; 1994 Jan; 23(1 Suppl):I189-92. PubMed ID: 8282356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bradykinin B1 receptors in the rabbit urinary bladder: induction of responses, smooth muscle contraction, and phosphatidylinositol hydrolysis.
    Butt SK; Dawson LG; Hall JM
    Br J Pharmacol; 1995 Feb; 114(3):612-7. PubMed ID: 7735687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tonin and kallikrein-kinin system.
    Feitosa MH; Pesquero JL; Ferreira MA; Oliveira GM; Rogana E; Beraldo WT
    Adv Exp Med Biol; 1989; 247A():573-80. PubMed ID: 2557755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic kinin receptor blockade induces hypertension in deoxycorticosterone-treated rats.
    Madeddu P; Anania V; Parpaglia PP; Demontis MP; Varoni MV; Fattaccio MC; Glorioso N
    Br J Pharmacol; 1993 Mar; 108(3):651-7. PubMed ID: 8385532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of chronic bradykinin B2 receptor blockade on blood pressure of conscious Dahl salt-resistant rats.
    Mukai H; Fitzgibbon WR; Ploth DW; Margolius HS
    Br J Pharmacol; 1998 May; 124(1):197-205. PubMed ID: 9630360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kallistatin is a potent new vasodilator.
    Chao J; Stallone JN; Liang YM; Chen LM; Wang DZ; Chao L
    J Clin Invest; 1997 Jul; 100(1):11-7. PubMed ID: 9202051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substrate specificities of tissue kallikrein and T-kininogenase: their possible role in kininogen processing.
    Chagas JR; Hirata IY; Juliano MA; Xiong W; Wang C; Chao J; Juliano L; Prado ES
    Biochemistry; 1992 Jun; 31(21):4969-74. PubMed ID: 1599922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the antagonistic actions of HOE 140 and other novel bradykinin analogues on the guinea-pig ileum.
    Griesbacher T; Lembeck F
    Eur J Pharmacol; 1992 Feb; 211(3):393-8. PubMed ID: 1618275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Active-site labeling of rat and human urinary kallikrein by chloro(N alpha-p-tosyllysyl)methane.
    Chao J
    Hoppe Seylers Z Physiol Chem; 1981 Aug; 362(8):1113-8. PubMed ID: 6921142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The inhibition of glandular kallikrein by peptide analog antagonists of bradykinin.
    Spragg J; Vavrek RJ; Stewart JM
    Peptides; 1988; 9(1):203-6. PubMed ID: 3362744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.